The Effect of Oat Processing on Gastric Emptying and Satiety Induced After Consuming Porridge (Oatmet)

This crossover study is designed to compare the gastric layering and rates of emptying and by inference rates of digestion of two different porridge meals prepared from either finely milled or flaked oats. On each of two study days, a total of 9 MRI scans will be taken, I baseline and 8 post meal, to assess gastric layering and emptying over three hours. Blood samples will also be taken periodically over the same period in order to determine changes in concentrations of circulating glucose, insulin and key gastrointestinal hormones. Participants will also be asked to complete a questionnaire at predetermined times to assess feelings of satiation.

Study Overview

• Status: Completed
• Conditions: Metabolic Syndrome
• Intervention / Treatment: Other: Flaked oats; Other: Milled oats

Detailed Description

Eight participants will be recruited onto the study via the Human Nutrition Unit (HNU) Volunteer Database, advertising fliers and social media. Potential participants will be invited to IFR for a talk about the study, followed by health screening if they wish to participate. Written, informed consent will be taken by a member of the research team prior to undertaking any study related procedures.

Each participant will undergo 2 study days (min.7 days apart) and they will eat 2 types of porridge in a random order. Allocation of the order of the porridge meals will be done before the participants are recruited onto the study, using an online randomizer. On one occasion participants will consume porridge made from milled oats and on the other occasion porridge made from flaked oats. Participants will undergo 9 MRI scans of the stomach over a 3h post ingestion period, and after each scan a 4 ml blood sample will be collected via an intravenous cannula. Feelings of satiety will be assessed using a short VAS questionnaire at 9 intervals during the study day.

Study day participants will not be able to eat any food after 10.00pm on the evening prior to each study day, but they will be allowed water until they go to bed. Participants will be asked to record what they have eaten on the evening prior to study day 1, and they will be asked to eat the same foods on the evening before the second study day. Participants must not consume any breakfast on the morning of the study day, but they can drink up until 7 am. The study day will start at 9 am at the Radiology Department at the Norfolk and Norwich University Hospital. After cannulation and blood sampling, initial baseline MRI scans and VAS questionnaires, the participants will eat the allocated porridge (264 g) and drink the water provided (175 ml). They will then undergo 8 more MRI scans, have blood taken 8 more times and complete 8 satiety questionnaires at specific time points.

After completion of all MRI scans, blood sampling and satiety questionnaires, participants will be provided with a 500 ml bottle of water and a packed lunch.

• Study Type: Interventional
• Enrollment (Actual): 8
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Norfolk
    • Norwich, Norfolk, United Kingdom, NR4 7UA
      • Institute of Food Research

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 55 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Male

Description

Inclusion Criteria:

• Male (hormonal status of women would introduce more variation within small group)
• Age 20-55y (people older than the upper age limit for the study, may suffer from degeneration of the GI tract, which would compromise our study data).
• BMI 19-35 kg/m2
• Apparently healthy
• Normally eat lunch and breakfast
• Willing to eat porridge type meal
• Willing to be cannulated and have blood samples taken
• Be able provide written informed consent

Exclusion Criteria:

Potential participants will be excluded if:

• They are line managed or supervised by any members of the study team either at IFR or NNUHFT Radiology.
• They are a student with a dependency on any member of the NNUHFT/ IFR study team.
• They are related to or living with any member of the study team (NNUHFT or IFR).
• They have an intense dislike of/ intolerance / allergy to any of the constituents of the test meal.
• They are smokers or have smoked within the last year (smoking affects satiety/hunger); this also includes e-cigarettes.
• They have been diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease.
• They have had surgery on the stomach or intestine or suffered from oesophageal or gastrointestinal disease, whether diagnosed or self-reported.
• They currently suffer from, or have suffered from an eating disorder.
• They are taking antibiotics on a long-term basis.
• They regularly (more than once in 10 days) use antacids, laxatives.
• They have any problems with swallowing.
• They take prescribed or over the counter medication for digestive or gastrointestinal conditions.
• They are receiving anticoagulant therapy or have finished anticoagulant therapy within the previous week.
• They are taking any dietary supplements/ herbal remedies which may affect the study data unless they are willing to stop taking within the appropriate timescale for the study. These will be assessed on an individual basis.
• They are currently using Ginko supplements (unless the individual is willing to stop taking the supplements for a minimum of 1 week before screening and for the duration of the study).
• They are taking part in another research study (other than a questionnaire based study).
• Their blood pressure greater than 160/100 mmHg or less than 90/50 or 95/55 mmHg if symptomatic.
• They have any special dietary requirements (e.g. dairy-free).
• They have participated in a research study during the previous four months where the combined blood sampling from previous study and this study would exceed 470 ml.
• Any of the clinical screening results are indicative of a health problem which could affect the participants' well-being or which would affect the study data if they took part.
• The HbA1c result greater than 42 mmol/ ml.
• They are unwilling or unable to provide GP details.
• They refuse to give permission to inform GP of participation in study.
• They are not registered with a GP in the UK
• They have recently experienced unexplained weight gain or loss.
• They have a history of back problems or any other condition which limit ability to repeatedly sit up and lie down.
• They have a Hiatus Hernia.

MRI scanning specific exclusion criteria:

Potential participants will also be excluded from the study if they:

• Have a cardiac pacemaker or artificial heart valve.
• Have had any surgery in the last 6 months.
• Have aneurysm clips (metal clips from surgery).
• Have an implant, pump or any medical device in the body (e.g. cochlear implant, neurostimulator, intra-venticular shunt).
• Have worked with metals (using lathes or grinders) or sustained injury to eyes involving metal splinters or fillings.
• Have artificial eyes or limbs.
• Have been injured with shrapnel or bullets.
• Have a metal tattoo.
• Suffer from fits, blackouts or epilepsy.
• Suffer from claustrophobia.

Clinical screening exclusion criteria:

Potential participants will be excluded if clinical screening results deemed by the HNU Medical Advisor, to be indicative of a health problem which may compromise the well-being of the participant, or which could affect the study data.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Milled followed by flaked oats; Participant consumes test meal consisting of porridge made from milled oats on study day 1, followed by porridge made from flaked oats on study day 2	Other: Flaked oats; Test meal consisting of 264g porridge made with flaked oats; Other: Milled oats; Test meal consisting of 264g porridge made with milled oats
Experimental: Flaked followed by milled oats; Participant consumes test meal consisting of porridge made from flaked oats on study day 1, followed by porridge made from milled oats on study day 2	Other: Flaked oats; Test meal consisting of 264g porridge made with flaked oats; Other: Milled oats; Test meal consisting of 264g porridge made with milled oats

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Volume of gastric content	Three dimensional MRI data will be used to determine the volume of gastric content at each time point and thus allow the calculation of gastric emptying rate	3 hours

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Satiety response	A visual analogue scale questionnaire will be used to assess satiety response at each time point.	3 hours

Collaborators and Investigators

• Sponsor: Quadram Institute Bioscience
• Collaborators: Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
• Investigators: Principal Investigator: Alan R Mackie, PhD, Quadram Institute Bioscience

Study record dates

Study Major Dates

• Study Start: November 1, 2015
• Primary Completion (Actual): May 1, 2016
• Study Completion (Actual): May 1, 2016

Study Registration Dates

• First Submitted: January 12, 2016
• First Submitted That Met QC Criteria: January 13, 2016
• First Posted (Estimate): January 14, 2016

Study Record Updates

• Last Update Posted (Estimate): September 2, 2016
• Last Update Submitted That Met QC Criteria: August 31, 2016
• Last Verified: January 1, 2016

More Information

Terms related to this study

• Keywords: MRI; porridge; satiety; oats; processing; GI hormones
• Additional Relevant MeSH Terms: Glucose Metabolism Disorders; Metabolic Diseases; Insulin Resistance; Hyperinsulinism; Metabolic Syndrome
• Other Study ID Numbers: IFR08/2014